Questions? Call us at (888) 732-2375

1x
HOW IT WORKS FAQs SERVICES
☰

Forever Labs Blog

The latest news and research from Forever Labs

Life's Little Choices

posted by: Ann Hozeska-Solgot

The truth of the matter is the choices we make in life, over time, do have an effect on our bodies, and their impact over years influences the process of aging. Banking your stem cells with Foreve...

Forever Labs to Utilize Data Collection Platform DataBiologics

posted by: Cristina Sacchi

Forever Labs, the parent company of SuperShot® PRP, will utilize DataBiologics to track outcomes for their innovative PRP process that allows autologous extracellular vesicles to be isolated.

A Stem Cell Refresh Extends Lifespan

posted by: Mark Katakowski

In a previous blog post, I mentioned that one of the most compelling potential uses of our banked cells is using them to rejuvenate ourselves by transplanting our young stem cells into our older se...

Mark Katakowski talks Forever Labs and more on a Cake Panel!

posted by: Sean Robenalt

Forever Labs President Mark Katakowski talks about the past, present, and future with Victoria at Cake. Read their conversation here!    

When Can I Use My Stem Cells?

posted by: Mark Katakowski

I get asked this question a lot. I do not know when you will use your stem cells, or what you will use them for. I will say that you shouldn’t be using your stem cells today, and you shouldn’t be u...

Mark Katakowski and Steven Claustnitzer interviewed on Aaron Watson's Going Deep podcast

posted by: Sean Robenalt

Forever Labs President Mark Katakowski & CEO Steven Clausnitzer discuss the benefits and rationale of stem cell storage with Aaron Watson: http://www.goingdeepwithaaron.com/podcast/262-why-yo...

Young donor stem cells improve frailty in a clinical trial: What if they had their own younger cells?

posted by: Mark Katakowski

In my last blog post, I discussed our plan to transplant our own younger mesenchymal stem cells (MSCs) to our older selves for the purposes of rejuvenation. Interestingly, a clinical trial was rece...

Mark Katakowski, Talks at Google: "Increasing Human Life Expectancy through Stem Cell Rejuvenation"

posted by: Sean Robenalt

Forever Labs President, Mark Katakowski discusses the potential to increase human life expectancy with stem cell rejuvenation in his Talk at Google.

Mary’s Forever Labs Story

posted by: Sean Robenalt

What is the Forever Labs procedure like? Mary, a health-conscious 35-year-old nurse, recently shared her Forever Labs stem cell collection experience at Davis & Pyle Plastic Surgery, in Raleigh...

Stem Cell Research Updates

Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice.

posted by: Mark Katakowski

As human lifespan increases, a greater fraction of the population is suffering from age-related cognitive impairments, making it important to elucidate a means to combat the effects of aging. Here ...

Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial.

posted by: Mark Katakowski

OBJECTIVE To assess in multiple sclerosis (MS) the effect of intense immunosuppression followed by autologous hematopoietic stem cells transplantation (AHSCT) vs mitoxantrone (MTX) on disease activ...

Cells derived from young bone marrow alleviate renal aging.

posted by: Mark Katakowski

Bone marrow-derived stem cells may modulate renal injury, but the effects may depend on the age of the stem cells. Here we investigated whether bone marrow from young mice attenuates renal aging in...

Effect on lifespan of high yield non-myeloablating transplantation of bone marrow from young to old mice.

posted by: Mark Katakowski

Tissue renewal is a well-known phenomenon by which old and dying-off cells of various tissues of the body are replaced by progeny of local or circulating stem cells (SCs). An interesting question i...

Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells.

posted by: Mark Katakowski

Human bone marrow-derived mesenchymal cells contain mesenchymal stem cells (MSCs), which are well known for their osteo/chondrogenic potential and can be used for bone reconstruction. This article ...

Long-term cryopreservation of bone marrow for autologous transplantation.

posted by: Mark Katakowski

Little is known about the effect of long-term cryopreservation on the viability of hematopoietic stem cells (HSC) or on the success of autologous bone marrow transplantation. Although progenitor ce...

Transplantation of mesenchymal stem cells from young donors delays aging in mice.

posted by: Mark Katakowski

Increasing evidence suggests that the loss of functional stem cells may be important in the aging process. Our experiments were originally aimed at testing the idea that, in the specific case of a...

Stem cell transplantation improves aging-related diseases.

posted by: Mark Katakowski

Aging is a complex process of damage accumulation, and has been viewed as experimentally and medically intractable. The number of patients with age-associated diseases such as type 2 diabetes mell...

Donor's age dependent proliferation decrease of human bone marrow mesenchymal stem cells is linked to diminished clonogenicity.

posted by: Mark Katakowski

While mesenchymal stem cells represent an interesting cell source for regenerative medicine, several points have to be investigated to improve their use in clinical, and in particular in the elder...